The association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV.
Ontology highlight
ABSTRACT: Benzodiazepine use is linked to neurocognitive impairment (NCI) in the general population and people with HIV (PWH); however, this relationship may depend on age-related factors such as medical comorbidities, which occur at an elevated rate and manifest earlier in PWH. We retrospectively examined whether chronological age or medical burden, a clinical marker for aging, moderated the relationship between benzodiazepine use and NCI in PWH. Participants were 435 PWH on antiretroviral therapy who underwent neurocognitive and medical evaluations, including self-reported current benzodiazepine use. A medical burden index score (proportion of accumulated multisystem deficits) was calculated from 28 medical deficits. Demographically corrected cognitive deficit scores from 15 neuropsychological tes
SUBMITTER: Sundermann EE
PROVIDER: S-EPMC9470605 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA